banner
OCT-modified dihydroartemisinin liposomes
Inquiry

Cat. No.: X26-05-ZQ2346

OCT-modified dihydroartemisinin liposomes

Synonym: OCT-modified dihydroartemisinin LPs; OCT-modified DHA liposomes; OCT-functionalized dihydroartemisinin liposomes

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This advanced engineered formulation features octreotide peptide functionalized dihydroartemisinin liposomes (OCT-modified dihydroartemisinin liposomes). The structural matrix incorporates the hydrophobic sesquiterpene lactone compound dihydroartemisinin directly within the lipophilic hydrocarbon tail domains of a phospholipid bilayer shell, whose exterior surface is functionalized with specific octreotide (OCT) somatostatin receptor-targeting peptides linked via polymer-lipid anchors. This precise modification alters the interfacial water structure and introduces a dense target-mimetic macromolecular array, completely preventing physical vesicle aggregation while controlling the passive leakage or phase separation of the volatile sesquiterpene core cargo.
Source
Custom synthesis
Functional Group
Octreotide (OCT); Dihydroartemisinin
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.